SCHEMBL22345562

SCHEMBL22345562

CCOP(=O)(Cc1cnnc2ccccc12)OCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 1/20 0.44
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ LMNA P02545 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ NR1I2 O75469 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.35
▸ EGFR P00533 2/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ CCNT1 O60563 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ HIF1A Q16665 1/20 0.33
▸ GPR3 P46089 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22345395 0.87 NR1I2 (0.38) NPY5RMEN1KMT2ALMNAKDM4E
SCHEMBL22345378 0.86 KDM4E (0.38) NPY5RMEN1KMT2ALMNAKDM4E
SCHEMBL22345431 0.78 MEN1 (0.42) NPY5RMEN1KMT2ALMNAKDM4E
SCHEMBL9601957 0.78 LOXL2 (0.47) NPY5RMEN1KMT2ALMNAKDM4E
SCHEMBL11751939 0.77 KDM4E (0.44) NPY5RLMNAKDM4EHPGDNR1I2
SCHEMBL9114839 0.77 GPR3 (0.46) MEN1KMT2ALMNAKDM4EHPGD
SCHEMBL22345518 0.75 MEN1 (0.36) NPY5RMEN1KMT2ALMNAKDM4E
SCHEMBL22345526 0.75 NPY5R (0.43) NPY5RMEN1KMT2ALMNAKDM4E
SCHEMBL702504 0.75 NPSR1 (0.47) LMNAKDM4EHPGDNR1I2NPSR1
Iodide SCHEMBL22345589 0.74 NPY5R (0.42) NPY5RMEN1KMT2ALMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220132847-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH SYNGENTA CROP PROTECTION AG (CH) 2022-05-05 — — US disclosed
US-20220132847-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH SYNGENTA CROP PROTECTION AG (CH) 2022-05-05 — — US disclosed
EP-3924344-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH Syngenta Crop Protection AG (CH) 2021-12-22 — — EP disclosed
CN-113423694-A Cinnolinium compounds for use in a method for controlling unwanted plant growth 先正达农作物保护股份公司 2021-09-21 — — CN disclosed
WO-2020164970-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH SYNGENTA CROP PROTECTION AG (CH) 2020-08-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220132847-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH NOTUM, DDT, CYP51A1 NPY5R 2032/4885MEN1 603/4885KMT2A 3742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback